Work

Phase I dose-escalation trial of tremelimumab in combination with bicalutamide in patients with recurrent prostate cancer.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.7_suppl.174

Authors: J. M. Lang, M. J. Staab, G. Liu, G. Wilding, D. G. McNeel

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2560267721

Cites:

Cited by: 3

Related to: 10